NSB 2.56% 4.0¢ neuroscientific biopharmaceuticals ltd

Ann: Westar Capital Investor Presentation, page-3

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 135 Posts.
    lightbulb Created with Sketch. 21
    Looks like NSB are looking to out-licence their product post Phase 1 clinical trials. This has it's own pros and cons. For those not familiar with in/out licencing process the below link will help explain.
    https://investingnews.com/daily/life-science-investing/pharmaceutical-investing/what-is-in-licensing/
 
watchlist Created with Sketch. Add NSB (ASX) to my watchlist
(20min delay)
Last
4.0¢
Change
0.001(2.56%)
Mkt cap ! $5.784M
Open High Low Value Volume
3.8¢ 4.1¢ 3.8¢ $27.54K 691.5K

Buyers (Bids)

No. Vol. Price($)
1 38512 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 12500 1
View Market Depth
Last trade - 15.26pm 11/10/2024 (20 minute delay) ?
NSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.